Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 15, 2020 - Issue 3
Submit an article Journal homepage
465
Views
4
CrossRef citations to date
0
Altmetric
Review

Hypertonic saline, isotonic saline, water restriction, long loops diuretics, urea or vaptans to treat hyponatremia

Guy DecauxDepartment of Internal Medicine, Erasmus University Hospital, ULB, Brussels, BelgiumCorrespondence[email protected]
View further author information
&
Fabrice Gankam KengneDepartment of Nephrology, Centre EpiCURA, Ath, BelgiumView further author information
Pages 195-214 | Received 12 Dec 2019, Accepted 09 Apr 2020, Published online: 13 May 2020

  • Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337:169–172.
  • Gankam Kengne F. Physiopathology, clinical diagnosis, and treatment of hyponatremia. Acta Clin Belg. 2016;71(6):359–372.
  • Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatremia. NDT. 2014;29(Suppl 2):i1–i39.
  • Fujisawa H, Sugimura Y, Takagi H, et al. Chronic hyponatremia causes neurologic and psychological impairments. J Am Soc Nephrol. 2016;27(3):766–780.
  • Renneboog B, Musch W, Vandermergel X, et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119(1): e71–e78.
  • Renneboog B, Sattar L, Decaux G. Attention and postural balance are much more affected in older than in younger adult with mild or moderate chronic hyponatremia. Eur J Intern Med. 2017;41:e25–e26.
  • Gankam Kengne F, Andres C, Sattar L, et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. Q J Med. 2008;101(7): 583–588.
  • Verbalis JG, Barsony J, Sugimura Y, et al. Hyponatremia induced osteoporosis. JBMR. 2010;25(3): 554–563.
  • Usala RL, Fernandez SJ, Mete M, et al. Hyponatremia is associated with increased osteoporosis and bone fractures in a large US health system population. JCEM. 2015;100(8):3021–3031.
  • Corona G, Giuliani C, Parenti G, et al. Moderate hyponatremia is associated with increased risk of mortality: evidence from meta-analysis. Plos One. 2013;18(12):e–80451.
  • Corona G, Giuliani C, Verbalis JG, et al. Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. Plos One. 2015;10(4):e0124105.5.
  • Chung HM, Kluge R, Schrier RW, et al. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med. 1987;83:905–908.
  • Musch W, Thimpont J, Vandervelde D, et al. Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than also usual clinical and biochemical parameters. Am J Med. 1995;99:348–355.
  • Shapiro JS, Anderson RJ. Sodium-depletion states. Contemp Nephrol. 1987;16:245–276.
  • Musch W, Verfaillie L, Decaux G. Age-related increase in plasma urea level and decrease in fractional urea excretion: clinical application in the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. 2006;1(6):1154–1160.
  • Musch W, Decaux G. Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly. Intern Urol Nephrol. 2001;3:475–493.
  • Diringer MN, Wu KC, Verbalis JG, et al. Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid haemorrhage. Ann Neurol. 1992;31:543–550.
  • Brimioulle S, Orellana-Jimenz C, Aminian A, et al. Hyponatremia in neurological patients: cerebral salt wasting versus inappropriate anti-diuretic hormone secretion. Int Care Med. 2008;34:125–131.
  • Ware JS, Wain JL, Channavajjhala SK, et al. Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia. J Clin Invest. 2017;127(9):3367–3374.
  • Musch W, Decaux G. High fractional potassium excretion in symptomatic hyponatremia. Eur J Int Med. 2019;59:e9–e10.
  • Decaux G, Schlesser M, Coffernils M, et al. Uric acid, anion gap and urea concentration n the diagnostic approach to hyponatremic patients. Clin Nephrol. 1994;42(N° 2):102–108.
  • Musch W, Decaux G. Severe solute depletion in patients with hyponatremia due to diuretics despite biochemical pictures similar than those observed in the syndrome on inappropriate secretion of antidiuretic hormone. Nephron. 2018;140(1):31–38.
  • Musch W, Decaux G. Hyponatremia secondary to transient renal salt wasting (TRSW): a not so uncommon observation in the elderly. Clin Nephrol. 2019;91(6):344–352.
  • Michelis MF, Warms PC, Fusco RD, et al. Hypouricemia and hyperuricosuria in Laennec cirrhosis. Arch Intern Med. 1974;134:681–683.
  • Decaux G, Prospert F, Namias B, et al. Raised urea clearance in cirrhotic patients with high uric acid clearance is related to low salt excretion. Gut. 1992;33:1105–1108.
  • Berl T. Impact of solute intake on urine flow and water excretion. J Am Soc Nephrol. 2008;19(6):1076–1078.
  • Verhoeven A, Musch W, Decaux G. Treatment of the polydipsia-hyponatremia syndrome with urea. J Clin Psychiatry. 2005;66:1372–1375.
  • Zelingmer J, Putterman C, Ilass Y, et al. Case series: hyponatremia associated with moderate exercise. Am J Med Sci. 1996;311:86–91.
  • Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and non cardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711–714.
  • Nolph KD, Schrier RW. Sodium, potassium and water metabolism in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med. 1970;49(4):534–545.
  • Decaux G, Crenier L, Namias B, et al. Low plasma bicarbonate level in hyponatremia related to adrenocorticotropin deficiency. J Clin Endocrinol Metab. 2003;88:5255–5257.
  • Decaux G, Prospert F, Soupart A, et al. Evidence that chronicity of hyponatremia contributes to the high urate clearance observed in the syndrome of inappropriate antidiuretic hormone secretion. Am J Kidney Dis. 2000;36(4):745–751.
  • Decaux G, Namias B, Gulbis B, et al. Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance. J Am Soc Nephrol. 1996;7(5):805–810.
  • Decaux G, Genette F, Mockel J. Hypouremia in the syndrome of inappropriate secretion of antidiuretic hormone. Ann Intern Med. 1980;93(5):589–590.
  • Decaux G, Vandergheynst F, Bouko Y, et al. Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol. 2007;18(2):606–612.
  • Fenske WK, Christ-Crain M, Horming A, et al. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis. J Am Soc Nephrol. 2014;25:2376–2383.
  • Musch W, Hedeshi G, Decaux G. Low sodium excretion in SIADH patients with low diuresis. Nephron Physiol. 2004;96(1):11–18.
  • Musch W, Decaux G. Treating the syndrome of inappropriate ADH secretion with isotonic saline. QJM. 1998;91(11):749–753.
  • Gankam-Kengne F, Decaux G. Hyponatremia and the brain. Kidney Int Rep. 2018;3(1):24–35.
  • Verbalis JG, Gullans SR. Rapid correction of hyponatremia produces differential effects on brain osmolyte and electrolyte reaccumulation in rats. Brain Res. 1993;606(1):19–27.
  • Ayus JC, Arieff AL. Pulmonary complications of hyponatremia encephalopathy. Noncardiogenic pulmonary edema and hypercapnic respiratory failure. Chest. 1995;107(2):517–521.
  • Soupart A, Penninckx R, Stenuit A, et al. Treatment of chronic hyponatremia in rats by intravenous saline: comparison of rate versus magnitude of correction. Kidney Int. 1992;41:1662–1667.
  • Soupart A, Penninckx R, Stenuit A, et al. Lack of major hypoxia and significant brain damage in rats despite dramatic hyponatremic encephalopathy. J Lab Clin Med. 1997;130(2):226–231.
  • Soupart A, Penninckx R, Crenier L, et al. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering. Kidney Int. 1994;45:193–200.
  • Soupart A, Penninckx R, Stenuit A, et al. Reinduction of hyponatremia improves survival in rats with myelinolisis-related neurologic symptoms. J Neuropathol Exp Neurol. 1996;55:594–601.
  • Gankam-Kengne F, Soupart A, Pochet R, et al. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int. 2009;76:614–621.
  • Soupart A, Gassa N, Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol. 1999;51:383–386.
  • Oya S, Tsutsumi K, Ueki K, et al. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology. 2001;57(10):1931–1932.
  • Ochiai H, Venishi E. Early relowering of serum sodium concentration overcomes disturbances in consciousness during hyponatremia overcorrection and prevents osmotic demyelination syndrome. Intern Med. 2018;57(16):2353–2357.
  • Aegisolottir H, Cooray C, Wirdefeldt K, et al. Incidence of osmotic demyelination syndrome in Sweden: a nationwide study. Acta Neurol Scand. 2019. DOI:10.1111/ane.13150.
  • Sandhu HS, Gilles E, De Vita MV, et al. Hyponatremia associated with large-bone fracture in elderly patients. Int Urol Nephrol. 2009;4(3):733–737.
  • Kinsella S, Moran S, Sullivan MO, et al. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol. 2010;5(2):275–280.
  • Horn EJ, Rivademiera F, van Meurs JB, et al. Mild hyponatremia as a risk factor for fractures: the Rotterdam Study. J Bone Miner Res. 2011;26(8):1822–1828.
  • Vandergheynst F, Gombeir Y, Bellante F, et al. Impact of hyponatremia of nerve conduction and muscle strength. Eur J Clin Invest. 2016;46(4): 328–333.
  • Sejling AS, Thorsteinsson AL, Perderson-Bjergaard U, et al. Recovery from SIADH-associated osteoporosis: a case report. J Clin Endo Metab. 2014;99(10):3527–3530.
  • Patel M, Ayus JC, Moritz ML. Fragility fractures and reversible osteopaenia due to chronic hyponatremia in an adolescent male. BMJ Case Rep. 2019;12(7):piie229875.
  • Cluitmans FHM, Meinders AE. Management of severe hyponatremia: rapid of slow correction? Am J Med. 1990;88:161–166.
  • Koenig MA, Bryan M, Lewin JL III, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70:1023–1029.
  • Decaux G, Gankam Kengne F, Couturier B, et al. Actual therapeutic indication of an old drug: urea for treatment of severely symptomatic and mild chronic hyponatremia related to SIADH. J Clin Med. 2014;3(3):1043–1049.
  • Decaux G, Andres C, Gankam-Kengne F, et al. Treatment of euvolemic hyponatremia in the intensive care unit by urea. Crit Care. 2010;14:R184.
  • Annoni F, Fontana V, Brimioulle S, et al. Early effects of enteral urea on intracranial pressure in patients with acute brain injury and hyponatremia. J Neurosurg Anesthesiol. 2017;29(4):400–405.
  • MacMillan TE, Tang T, Cavalcanti RB. Desmopressin to prevent rapid sodium correction in severe hyponatremia: a systematic review. Am J Med. 2015;128(12):1362-e15-24.
  • Perinayagam A, Sterns RH, Silver SM. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol. 2008;3:331–336.
  • Gequier E, Constant F. Water as an essential nutrient: the physiological basis of hydration. Eur J Clin Nutri. 2010;64:115–123.
  • Decaux G, Gankam Kengne F, Couturier B, et al. Mild water restriction with or without urea for the longterm treatment of SIADH: can urine osmolality help the choice? Eur J Intern Med. 2018;48:89–93.
  • Decaux G, Musch W. Estimated daily urine volume and solute excretion from spot urine samples to guide therapy of hyponatremia in SIADH. J Clin Med. 2019;8(10):1511.
  • Decaux G. V2-antagonists for treatment of hyponatremia. NDT. 2007;22-7:1853–1855.
  • Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355(20):2099–2112.
  • Owen BE, Roger IR, Hoffman MD, et al. Efficacy of oral versus intravenous hypertonic saline in runners with hyponatremia. J Sci Med Sport. 2014;17(5):457–462.
  • Musch W, Xhaet O, Decaux G. Solute loss plays a major role in polydipsia-related hyponatremia of both water drinkers and beer drinkers. Q J Med. 2003;96:421–426.
  • Decaux G. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by long loops diuretics. Nephron. 1983;365:82–88.
  • Decaux G, Waterlot Y, Genette F, et al. Inappropriate secretion of antidiuretic hormone treated by furosemide. Br Med J. 1982;285:89–90.
  • Packer M, Medina N, Yushak M. Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition. Ann Intern Med. 1984;100(66):782–789.
  • James JW, Evans RA. Use of oral mannitol in the oedematous patient. BMJ. 1970;1(5694):463–465.
  • Nelson DC, Grew M Jr, Hoyumpa AM Jr. Hypernatremia and lactulose therapy. JAMA. 1983;249(10):1295–1298.
  • Kelly H. Preliminary observations on a new approach of peptic ulcer and digestive disorders. Can Med Ass J. 1962;86:17–21.
  • Christopher L, Fitzerald O. A clinical trial of an oral urea preparation (carbamine) in peptic ulcer therapy. I J Med Sci. 1968;6:243–253.
  • Clark PI. The results of urea-treatment in liver malignancies. Br J Cancer. 1988;57:317–318.
  • Nalbandian RM, Anderson JW, Lusher JM, et al. Oral urea and the prophylactic treatment of sickle cell disease. A preliminary report. Am J Med Sci. 1971;261(6):325–334.
  • Pariser S, Katz A. Treatment of sickle cell trait hematuria with oral urea. J Urol. 1994;151:401–403.
  • Papp C, Smith KS. Urea the forgotten diuretic. Br Med J. 1957;19:906–911.
  • Miller HR, Feldman A. Prolonged use of massive doses of urea in cardiac dropsy. Arch Int Med. 1931;49:965–977.
  • Belda-Rustarazo S, Sameron-Garcia A, Gomez-Pena C, et al. Effectiveness of urea in hyponatremia secondary to hear failure and cirrhosis. Eur J Hosp Pharm. 2013;20:129–131.
  • Buckell M. Blood changes on intravenous administration of mannitol or urea for reduction of intracranial pressure in neurosurgical patients. Clin Sci. 1964;27:223–227.
  • Javid M. Urea-new use of an old agent. Reduction of intracranial and intraocular pressure. Surg Clin North America. 1958;38:907–928.
  • Watkings ES, Stubbes JD, Lewin W. Urea in the management of head injuries. Lancet. 1961;18:358–368.
  • Angelborg C, Klockhoff I, Stable J. Urea and hearing in patients with meniere’s disease. Scand Audiol. 1977;6(3):143–146.
  • Decaux D, Brimioulle S, Genette F, et al. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med. 1980;69:99–106.
  • Decaux G, Genette F. Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone. Br Med J. 1981;283:1081–1083.
  • Soupart A, Coffernils M, Couturier B, et al. Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. CJASN. 2012;7(5): 742–747.
  • Decaux G, Mols P, Cauchie P, et al. Use of urea for treatment of water retention in hyponatremia cirrhosis with ascites resistant to diuretics. Br Med J. 1985;290:1782–1783.
  • Decaux G, Mols P, Cauchie P, et al. Treatment of hyponatremia cirrhosis with ascites resistant to diuretics by urea. Nephron. 1986;44:337–343.
  • Cauchie P, Vincken W, Decaux G. Urea treatment for water retention in hyponatremic congestive heart failure. Int J Cardiol. 1987;17(1):102–104.
  • Reeders RF, Harbangh RE. Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. J Neurosurg. 1989;70:201–206.
  • Kleeman CR, Daison H, Levin E. Urea transport in the central nervous system. Am J Physiol. 1962;203:739–747.
  • Dormin HR, Sandheiner JH, Cadnapahomchal P. Mannitol induced acute renal failure. Medicine (Baltimore). 1990;69:153–159.
  • Vandergheynst F, Brachet C, Heinrichs C, et al. Long-term treatment of hyponatremic patients with nephrogenic syndrome of inappropriate antidiuresis: personal experience and review of published case reports. Nephron Clin Practice. 2012;42(3):249–254.
  • Soupart A, Decaux G, Coffernils M, et al. Tritherapy (saline, urea, desmopressin = SUD) as initial therapeutic regimen for sodium rate control in patients with severe hyponatremia of any origin. Acta Clin Belg. 2012;67(6):449.
  • Soupart A, Stenuit A, Perier O, et al. Limits of brain tolerance to daily increments in serum sodium in chronically hyponatremic rats treated with hypertonic aline or urea: advantage of urea. Clin Sci. 1991;80:77–84.
  • Soupart A, Penninckx R, Stenuit A, et al. Azotemia (48h) decreases the risk of brain damage in rats after correction of chronic hyponatremia. Brain Res. 2000;852(1):167–172.
  • Soupart A, Silver S, Schroëder B, et al. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol. 2002;13(6):1433–1441.
  • Soupart A, Schroeder B, Decaux G. Treatment of hyponatremia by urea decreases risks of brain complications in rats. Brain osmolytes content analysis. Nephrol Dial Transplant. 2007;22(7):1856–1863.
  • Gankam Kengne F, Couturier B, Soupart A, et al. Urea minimizes brain complication following rapid correction of chronic hyponatremia compared to vasopressin antagonist or hypertonic saline. Kidney Int. 2014;87(2):323–331.
  • Gankam Kengne F, Couturier B, Soupart A, et al. Osmotic stress induced defective glial proteostasis contributes to brain demyelination after hyponatremia treatment. J Am Soc Nephrol. 2017;28(6): 1802–1813.
  • Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation and treatment of hyponatremia. Am J Med. 2013;126(10 suppl 1):S1–S42.
  • Decaux G, Unger J, Brimioulle S, et al. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone: rapid correction with urea, sodium chloride and water restriction. JAMA. 1982;247:471–474.
  • Decaux G. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985. J Lab Clin Med. 2001;138(1):18–21.
  • Decaux G, Namias B, Gulbis G, et al. Effect of urea and indocid intake on solute excretion in the syndrome of inappropriate secretion of antidiuretic hormone. Nephron. 1993;64(1):47–52.
  • Verbalis JG, Baldwin EF, Neish PN, et al. Effect of protein intake and urea on sodium excretion during inappropriate antidiuresis in rats. Metabolism. 1988;37(1):46–55.
  • Decaux G, Dumont I, Waterlot Y, et al. Mechanisms of hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. Nephron. 1985;39:164–168.
  • Hauselamnn HJ, Studer H. Antinatriuretic effect of sulfinpryraone. Schweiz Med Wochenschr. 1981;111(27-28:1030.
  • Kawai N, Ishikawa K, Nemoto K, et al. Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia. J Clin Psychopharmacol. 2009;29(5):499–501.
  • Josiassen RC, Goldman M, Jessani M, et al. Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia. Biol Psychiatry. 2008;64(12):1097–1100.
  • Tripathy K, Klahr S, Lotero H. Utilization of exogenous urea nitrogen in malnourished adults. Metabolism. 1970;19-3:253–262.
  • Meakins TS, Jackson AA. Salvage of exogenous urea nitrogen enhances nitrogen balance in normal men consuming marginally inadequate protein diets. Clin Sci. 1996;90(3):215–225.
  • Shayakul C, Clémençon B, Hediger MA. The urea transporter family (SLC14): physiological, pathological and structural aspects. Mol Aspects Med. 2013;34(2–3):313–322.
  • Walpsol C, McGrane A, Al-Mausauri H, et al. Investigation of facilitative urea transporter in the human gastrointestinal tract. Physiol Rep. 2018;6-1:e13826.
  • Rondon-Berrios H, Tandukar S, Mor MK, et al. Urea for the treatment of hyponatremia. Clin J Am Soc Nephrol. 2018;13(11):1627–1632.
  • Lockett J, Berkman KE, Dimeshi G, et al. Urea treatment in fluid restriction-refractory hyponatremia. Clin Endocrinol. 2019;90:630–636.
  • Nervo A, D’Angelo V, Rosso D, et al. Urea in cancer patients with chronic SIAD-induced hyponatremia: old drug, new evidence. Clin Endocrinol (Oxf). 2019;90(6):842–848.
  • Brinkkoetter PT, Grundmann F, Ghassabeh PJ, et al. Impact of resolution of hyponatremia on neurocognitive and motor performance in geriatric patients. Sci Rep. 2019;9(1):12526.
  • Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancer. 2008;371:1624–1632.
  • Watkins PB, Lewis JH, Kaplowitz N, et al. Clinical pattern of Tolvaptan-associated liver injury in subjects with autosomal dominant polycystic kidney disease: analysis of clinical trials database. Drug Saf. 2015;38:1103–1113.
  • Yan L, Xie F, Lu J, et al. The treatment of vasopressin V2-receptor antagonists in cirrhosis patient with ascites: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2015;15:65.
  • Li B, Fang D, Qian C, et al. The efficacy and safety of Tolvaptan in patients with hyponatremia: a meta-analysis of randomized controlled trials. Clin Drug Investig. 2017;37(4):327–342.
  • Hirai K, Shimonmura T, Moriwaki H, et al. Risk factors for hypernatremia in patients with short-and longterm Tolvaptan treatment. Eur J Clin Pharmacol. 2016;72(10):1177–1183.
  • Fuca G, Mariani L, Lo Vullo S, et al. Weighting the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS Study. Sci Rep. 2019 sep 10;9(1):12993.
  • Berardi R, Santoni M, Newson-Davis T, et al. Hyponatremia normalization as an independent prognostic factors in patients with advanced non-small cell lung cancer treated with first-line therapy. Oncotarget. 2017;8(14):23871–23879.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.